Drugs - Real World Outcomes
Last updated ISSN 2198-9788
Drugs - Real World Outcomes is published by Adis, Springer Healthcare in pharmacology, toxicology and pharmaceutics. It is open access. The article processing charge is $3,090.
Is your paper a fit?
The surest way to know is to compare your own abstract against what this journal has actually been publishing, rather than against its aims-and-scope page. Paste your abstract and Journal Hunt will tell you how close Drugs - Real World Outcomes is — and show you journals like it.
What it publishes
Recent work in Drugs - Real World Outcomes concentrates on these topics, taken from its published record rather than from its own description:
- Pharmacovigilance and Adverse Drug Reactions
- Pharmaceutical Practices and Patient Outcomes
- Medication Adherence and Compliance
- Heart Failure Treatment and Management
- Rheumatoid Arthritis Research and Therapies
- Antibiotic Use and Resistance
- Schizophrenia research and treatment
- Atrial Fibrillation Management and Outcomes
- Opioid Use Disorder Treatment
- Diabetes Treatment and Management
Key facts
| Publisher | Adis, Springer Healthcare |
|---|---|
| ISSN | 2198-9788, 2199-1154 |
| Subject area | Pharmacology, Toxicology and Pharmaceutics |
| Access | Open access |
| Article processing charge | $3,090 |
| Indexed in | Scopus · DOAJ |
| Articles published | 567 |
| Publishing since | 1990 |
| Journal website | link.springer.com/journal/40801 |
Facts come from OpenAlex, DOAJ and Wikidata and may lag the journal’s own pages. Check the publisher’s site before submitting. Indexing shown here is what is recorded, not a complete picture — about a third of journals have no indexing recorded anywhere we can read, so “not recorded” does not mean a journal is absent from Scopus or Web of Science.
Journals like Drugs - Real World Outcomes
Other established journals in pharmacology, toxicology and pharmaceutics, if this one is not the right home for your paper: